Has Anne Langguth, MD received payments from drug or device companies?

Yes. Drug and device makers reported $51,359 in general payments to Anne Langguth, MD across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anne Langguth, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anne Langguth, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anne Langguth, MD

Ophthalmology · Chicago, ILNPI 1255742300

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,738 of the $51,359 with a category attached, or 75.4%. Amgen accounts for 99.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $18,981, 6.3 times the $3,013 reported in 2020. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,359in general payments, 2019–2025

Across 83 payments — averaging $618.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$51K
Glaukos Corporation$203
The Cameron-ehlen Group, Inc.$108
Rayner Intraocular Lenses Limited$20
Alcon$18

What the payments were for

Consulting fees$6,30012%
Speaking & faculty fees$38,73875%
Travel & lodging$3,8257%
Food & beverage$2,4865%
Education$100%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	78	$51,010
Glaukos Corporation	1	$203
The Cameron-ehlen Group, Inc.	2	$108
Rayner Intraocular Lenses Limited	1	$20
Alcon	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,359 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois →

Medicare billing

Part B allowed, 2024

$13,268

Medicare patients

Services billed

103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Chicago

Seenu HariprasadChicago$2.3M
Yannek LeidermanChicago$312K
Asim FarooqChicago$270K
Dilraj GrewalChicago$188K
Ahmad ArefChicago$179K
Robert SchroederChicago$153K
Jennifer LimChicago$150K
Surendra BastiChicago$126K
Allen PuttermanChicago$94K
Maria CortinaChicago$88K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →